A recently published study suggests a high proportion of US cancer survivors using cannabis are doing so for medicinal purposes.Researchers from the University of...
Australia's MGC Pharmaceuticals has announced a definitive supply agreement that will see its first epilepsy medicine in the hands of Australian patients.The company has...
Regulatory changes were recently introduced in Western Australia for prescribing and dispensing Schedule 8 medicinal cannabis products.Products containing tetrahydrocannabinol (THC) are considered Schedule...